Literature DB >> 24837780

Effectiveness of typhoid vaccination in US travelers.

Barbara E Mahon1, Anna E Newton2, Eric D Mintz3.   

Abstract

Typhoid vaccination is recommended in the United States before travel to countries where typhoid fever is endemic, though little information is available on its effectiveness in travelers. We estimated typhoid vaccination effectiveness (VE) by comparing vaccination status in cases of typhoid fever and paratyphoid fever (Salmonella Paratyphi A infection, against which typhoid vaccine offers no protection) reported in the United States. We included travelers to Southern Asia and excluded persons <2 years old and cases in which vaccination status was not reported. From 2008 through 2011, 744 eligible cases (602 typhoid, 142 paratyphoid A) were reported to CDC. Typhoid vaccination was reported for 5% (29/602) of typhoid patients and for 20% (29/142) of paratyphoid A patients. Estimated VE was 80% (95% confidence interval, 66-89%). Because of missing data, we could not estimate VE for specific vaccines. We demonstrated moderate effectiveness of typhoid vaccination in US travelers, supporting vaccination recommendations. Published by Elsevier Ltd.

Entities:  

Keywords:  Travelers; Typhoid vaccination; United States; Vaccination effectiveness

Mesh:

Substances:

Year:  2014        PMID: 24837780      PMCID: PMC4604742          DOI: 10.1016/j.vaccine.2014.04.055

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  From the CDC: new country-specific recommendations for pre-travel typhoid vaccination.

Authors:  Katherine J Johnson; Nancy M Gallagher; Eric D Mintz; Anna E Newton; Gary W Brunette; Phyllis E Kozarsky
Journal:  J Travel Med       Date:  2011-10-14       Impact factor: 8.490

Review 2.  Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.

Authors:  Sushant Sahastrabuddhe; Rodney Carbis; Thomas F Wierzba; R Leon Ochiai
Journal:  Expert Rev Vaccines       Date:  2013-09       Impact factor: 5.217

3.  Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.

Authors:  C H Simanjuntak; F P Paleologo; N H Punjabi; R Darmowigoto; H Totosudirjo; P Haryanto; E Suprijanto; N D Witham; S L Hoffman
Journal:  Lancet       Date:  1991-10-26       Impact factor: 79.321

Review 4.  Health disparities among travelers visiting friends and relatives abroad.

Authors:  Sonia Y Angell; Martin S Cetron
Journal:  Ann Intern Med       Date:  2005-01-04       Impact factor: 25.391

5.  Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.

Authors:  Rezwanul Wahid; Raphael Simon; Shah J Zafar; Myron M Levine; Marcelo B Sztein
Journal:  Clin Vaccine Immunol       Date:  2012-04-04

6.  Typhoid fever in the United States, 1999-2006.

Authors:  Michael F Lynch; Elizabeth M Blanton; Sandra Bulens; Christina Polyak; Jazmin Vojdani; Jennifer Stevenson; Felicia Medalla; Ezra Barzilay; Kevin Joyce; Timothy Barrett; Eric Daniel Mintz
Journal:  JAMA       Date:  2009-08-26       Impact factor: 56.272

Review 7.  Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials.

Authors:  Abigail Fraser; Mical Paul; Elad Goldberg; Camilo J Acosta; Leonard Leibovici
Journal:  Vaccine       Date:  2007-09-04       Impact factor: 3.641

8.  Laboratory-based surveillance of paratyphoid fever in the United States: travel and antimicrobial resistance.

Authors:  Sundeep K Gupta; Felicita Medalla; Michael W Omondi; Jean M Whichard; Patricia I Fields; Peter Gerner-Smidt; Nehal J Patel; Kara L F Cooper; Tom M Chiller; Eric D Mintz
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

9.  IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine.

Authors:  A Tagliabue; L Villa; M T De Magistris; M Romano; S Silvestri; D Boraschi; L Nencioni
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

10.  Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B.

Authors:  Myron M Levine; Catterine Ferreccio; Robert E Black; Rosanna Lagos; Oriana San Martin; William C Blackwelder
Journal:  Clin Infect Dis       Date:  2007-07-15       Impact factor: 9.079

View more
  9 in total

1.  Changing Patterns in Enteric Fever Incidence and Increasing Antibiotic Resistance of Enteric Fever Isolates in the United States, 2008-2012.

Authors:  Kashmira A Date; Anna E Newton; Felicita Medalla; Anna Blackstock; LaTonia Richardson; Andre McCullough; Eric D Mintz; Barbara E Mahon
Journal:  Clin Infect Dis       Date:  2016-04-18       Impact factor: 9.079

2.  Epidemiological and Clinical Characteristics of International Travelers with Enteric Fever and Antibiotic Resistance Profiles of Their Isolates: a GeoSentinel Analysis.

Authors:  Stefan H F Hagmann; Kristina M Angelo; Ralph Huits; Katherine Plewes; Gilles Eperon; Martin P Grobusch; Anne McCarthy; Michael Libman; Eric Caumes; Daniel T Leung; Hilmir Asgeirsson; Mogens Jensenius; Eli Schwartz; Adrian Sánchez-Montalvá; Paul Kelly; Prativa Pandey; Karin Leder; Daniel L Bourque; Yukihiro Yoshimura; Frank P Mockenhaupt; Perry J J van Genderen; Silvia Odolini; Patricia Schlagenhauf; Bradley A Connor; Davidson H Hamer
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

3.  Updated recommendations for the use of typhoid vaccine--Advisory Committee on Immunization Practices, United States, 2015.

Authors:  Brendan R Jackson; Shahed Iqbal; Barbara Mahon
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-03-27       Impact factor: 17.586

4.  Salmonella enterica Paratyphi A Infections in Travelers Returning from Cambodia, United States.

Authors:  Michael C Judd; Julian E Grass; Eric D Mintz; Amelia Bicknese; Barbara E Mahon
Journal:  Emerg Infect Dis       Date:  2015-06       Impact factor: 6.883

Review 5.  Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures.

Authors:  Rupa R Patel; Stephen Y Liang; Pooja Koolwal; Frederick Matthew Kuhlmann
Journal:  Ther Clin Risk Manag       Date:  2015-02-12       Impact factor: 2.423

Review 6.  Guidelines for the prevention of travel-associated illness in older adults.

Authors:  Tida K Lee; Jack N Hutter; Jennifer Masel; Christie Joya; Timothy J Whitman
Journal:  Trop Dis Travel Med Vaccines       Date:  2017-06-13

7.  Salmonella Typhi, Paratyphi A, Enteritidis and Typhimurium core proteomes reveal differentially expressed proteins linked to the cell surface and pathogenicity.

Authors:  Sara Saleh; Sandra Van Puyvelde; An Staes; Evy Timmerman; Barbara Barbé; Jan Jacobs; Kris Gevaert; Stijn Deborggraeve
Journal:  PLoS Negl Trop Dis       Date:  2019-05-24

8.  Typhoid fever in travellers: estimating the risk of acquisition by country.

Authors:  Daniel P Forster; Karin Leder
Journal:  J Travel Med       Date:  2021-12-29       Impact factor: 8.490

Review 9.  Travel-Related Typhoid Fever: Narrative Review of the Scientific Literature.

Authors:  Narcisa Muresu; Giovanni Sotgiu; Bianca Maria Are; Andrea Cossu; Clementina Cocuzza; Marianna Martinelli; Sergio Babudieri; Riccardo Are; Marco Dettori; Antonio Azara; Laura Saderi; Andrea Piana
Journal:  Int J Environ Res Public Health       Date:  2020-01-18       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.